Key result
Anti-lubricin monoclonal antibodies specifically detected lubricin in synovial fluid and blood from healthy individuals and those with acquired joint disease, but not in patients with CACP who genetically lack the protein.
Answers are grounded in this paper and cite their sources.
Novel anti-lubricin monoclonal antibodies can detect lubricin in blood and synovial fluid, enabling diagnosis of CACP and potential monitoring of joint disease.
Lubricin, encoded by the gene PRG4, is the principal lubricant in articulating joints. We immunized mice genetically deficient for lubricin (Prg4-/-) with purified human lubricin, and generated several mAbs. We determined each mAb's binding epitope, sensitivity, and specificity using biologic samples and recombinant lubricin sub-domains, and we also developed a competition ELISA assay to measure lubricin in synovial fluid and blood. We found the mAbs all recognized epitopes containing O-linked oligosaccharides conjugated to the peptide motif KEPAPTTT. By western blot, the mAbs detected lubricin in 1 μl of synovial fluid from several animal species, including human. The mAbs were specific for lubricin since they did not cross-react with other synovial fluid constituents from patients with camptodactyly-arthropathy-coxa vara-pericarditis syndrome (CACP), who genetically lack this protein. The competition ELISA detected lubricin in blood samples from healthy individuals but not from patients with CACP, indicating blood can be used in a diagnostic test for patients suspected of having CACP. Lubricin epitopes in blood do not represent degradation fragments from synovial fluid. Therefore, although blood lubricin levels did not differentiate patients with inflammatory joint disease from healthy controls, epitope-specific anti-lubricin mAbs could be useful for monitoring disease activity in synovial fluid.
No takes yet. Share an insight, caveat, or question.
Ai et al. (2015) studied Camptodactyly-arthropathy-coxa vara-pericarditis syndrome (CACP), Rheumatoid Arthritis, Osteoarthritis (n=76). Anti-lubricin monoclonal antibodies vs. Healthy controls and CACP patients was evaluated on Serum lubricin levels in rheumatoid arthritis patients versus healthy controls (p=0.07). Anti-lubricin monoclonal antibodies specifically detected lubricin in synovial fluid and blood from healthy individuals and those with acquired joint disease, but not in patients with CACP who genetically lack the protein.
Synapse has enriched 10 related papers. Consider them for comparative context: